International Clinical Trial: A prospective, multicenter, non-interventional study on the prophylaxis of recurrent urinary tract infections with Cystohipp(R) (methenamine hippurate) to generate real-world evidence in routine urological care in Germany

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (DRKS00041029) titled 'A prospective, multicenter, non-interventional study on the prophylaxis of recurrent urinary tract infections with Cystohipp(R) (methenamine hippurate) to generate real-world evidence in routine urological care in Germany' on Sept. 8.

Study Type: observational

Study Design: Allocation: Masking: Control: Assignment: Study design purpose: prevention

Primary Sponsor: Dr. Pfleger Arzneimittel GmbH

Condition: N39.0 Urinary tract infection, site not specified

Intervention: Group 1: Female patients who suffer from recurrent urinary tract infections (rUTI) and are prescribed Cystohipp to prevent recurrence.

Recruitm...